These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29374508)

  • 1. Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications.
    Rattray Z; Dubljevic V; Rattray NJW; Greenwood DL; Johnson CH; Campbell JA; Hansen JE
    Biochem Biophys Res Commun; 2018 Feb; 496(3):858-864. PubMed ID: 29374508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-dependent targeting of cell nuclei by a lupus autoantibody.
    Weisbart RH; Chan G; Jordaan G; Noble PW; Liu Y; Glazer PM; Nishimura RN; Hansen JE
    Sci Rep; 2015 Jul; 5():12022. PubMed ID: 26156563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell-penetrating antibody inhibits human RAD51 via direct binding.
    Turchick A; Hegan DC; Jensen RB; Glazer PM
    Nucleic Acids Res; 2017 Nov; 45(20):11782-11799. PubMed ID: 29036688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells.
    Im SR; Im SW; Chung HY; Pravinsagar P; Jang YJ
    Mol Immunol; 2015 Oct; 67(2 Pt B):377-87. PubMed ID: 26189065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing a lupus autoantibody for targeted cancer therapy.
    Noble PW; Chan G; Young MR; Weisbart RH; Hansen JE
    Cancer Res; 2015 Jun; 75(11):2285-91. PubMed ID: 25832653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer with a lupus autoantibody.
    Hansen JE; Chan G; Liu Y; Hegan DC; Dalal S; Dray E; Kwon Y; Xu Y; Xu X; Peterson-Roth E; Geiger E; Liu Y; Gera J; Sweasy JB; Sung P; Rockwell S; Nishimura RN; Weisbart RH; Glazer PM
    Sci Transl Med; 2012 Oct; 4(157):157ra142. PubMed ID: 23100628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.
    Zack DJ; Yamamoto K; Wong AL; Stempniak M; French C; Weisbart RH
    J Immunol; 1995 Feb; 154(4):1987-94. PubMed ID: 7836777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
    Weisbart RH; Noritake DT; Wong AL; Chan G; Kacena A; Colburn KK
    J Immunol; 1990 Apr; 144(7):2653-8. PubMed ID: 2319132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a quadruplex DNA selective single-chain autoantibody from a viable motheaten mouse hybridoma with homology to telomeric DNA binding proteins.
    Brown JC; Brown BA; Li Y; Hardin CC
    Biochemistry; 1998 Nov; 37(46):16338-48. PubMed ID: 9819226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-establishing tolerance to DNA in humanized and murine models of SLE.
    Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
    Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage.
    Bloom DD; St Clair EW; Pisetsky DS; Clarke SH
    Eur J Immunol; 1994 Jun; 24(6):1332-8. PubMed ID: 8206093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody.
    Zack DJ; Stempniak M; Wong AL; Taylor C; Weisbart RH
    J Immunol; 1996 Sep; 157(5):2082-8. PubMed ID: 8757330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. J558 bias is not limited to classic lupus autoantibodies.
    Foster MH; MacDonald M; Barrett KJ; Madaio MP
    J Immunol; 1991 Sep; 147(5):1504-11. PubMed ID: 1908876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-damaging autoantibodies and cancer: the lupus butterfly theory.
    Noble PW; Bernatsky S; Clarke AE; Isenberg DA; Ramsey-Goldman R; Hansen JE
    Nat Rev Rheumatol; 2016 Jul; 12(7):429-34. PubMed ID: 27009542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors.
    Chen Z; Patel JM; Noble PW; Garcia C; Hong Z; Hansen JE; Zhou J
    Oncotarget; 2016 Sep; 7(37):59965-59975. PubMed ID: 27494868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement in lupus disease of idiotypes Id.F-423 and Id.IV-228 defined, respectively, upon foetal and adult MRL/Mp-lpr/lpr DNA-binding monoclonal autoantibodies.
    Ravirajan CT; Staines NA
    Immunology; 1991 Oct; 74(2):342-7. PubMed ID: 1748483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
    Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.